Transactions
3
Insider / Elanco Animal Health Inc
Ma Stacey
Director at Elanco Animal Health Inc
- Company
- Elanco Animal Health Inc
- Ticker
- ELAN
- First filing on record
- December 2, 2025
- Latest trade on record
- May 21, 2026
- SEC filings
- EDGAR ↗
Ma Stacey, Director at Elanco Animal Health Inc, has disclosed 3 transactions in ELAN since December 2, 2025: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed May 26, 2026, 5 days after the trade; 2 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
0
Avg. disclosure lag
4.7d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Ma Stacey reported 3 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 3 | 27,188 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 2 | 0 | 0 |
| 2025 | 1 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ELAN | Other A | May 21, 2026 | May 26, 2026 | 5d | 12,196 | — | — | late | Form 4 ↗ | |
| ELAN | Other A | May 21, 2026 | May 26, 2026 | 5d | 4,678 | — | — | late | Form 4 ↗ | |
| ELAN | Other A | November 28, 2025 | December 2, 2025 | 4d | 10,314 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 26, 2026 | Form 4 | 0001872431-26-000002 | 2 | published | EDGAR ↗ |
| December 2, 2025 | Form 4 | 0001872431-25-000004 | 1 | published | EDGAR ↗ |
Other insiders at Elanco Animal Health Inc
- Modi Rajeev A. SEE REMARKS 36 rows
- Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR 36 rows
- Kurzius Lawrence Erik Director 29 rows
- VanHimbergen Robert M EVP and CFO 28 rows
- de Brabander Ellen Director 16 rows
- Anand Kapila K Director 8 rows
- GARCIA ART A Director 8 rows
- Correia de Simas Jose Manuel SEE REMARKS 7 rows
- Bettington Timothy J SEE REMARKS 6 rows
- Kinard David S SEE REMARKS 6 rows
Everyone on file, with contracts and lobbying under the company's name: Elanco Animal Health Inc.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 3 | December 2, 2025 | May 26, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.